Not possible to specify

441 trials 102 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

Bioequivalence clinical trial of two formulations of sacubitril/valsartan Ended

2023-505237-27-00 Healthy volunteers 2 2023-06-02
Open label, Phase I study to assess and compare the pharmacokinetic parameters after multiple oral administration of stiripentol 1000 mg in … Ended

2024-516655-40-00 Patients with renal impairement 3 2023-06-02
Bioequivalence clinical trial of two formulations of apixaban Ended

2023-503970-19-00 Healthy volunteers 2 2023-03-31
Bioequivalence clinical trial of two formulations of sacubitril/valsartan Ended

2022-503083-32-00 Healthy volunteers 2 2023-03-08
Prophylaxis of venous thromboembolic disease with LMWH (TINzaparin) in patients with metastatic colorectal cancer who start the first line o… Ended

2023-508860-31-00 Stage IV colon or rectal adenocarcinoma (mCRC). 5 2023-02-28
R3R01 in Alport Syndrome Patients and Primary Steroid-Resistant Focal Segmental Glomerulosclerosis Ended

2024-512964-73-00 Alport Syndrome (AS) and Primary Steroid-Resistent Foca 4 2023-01-18
SAD/MAD study with PTC844 Ended

2022-501986-38-00 Auto immune disorders 1 2022-12-30
An investigation of heart-lung support without blood thinners during lung transplantation. Ended

2024-519503-10-00 Lung transplantation 6 2022-12-09
Bioequivalence clinical trial of two formulations of rosuvastatin/ezetimibe. Ended

2022-501862-24-00 Healthy volunteers 2 2022-11-25
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Subcutaneous Injections of NNC0582-0001 in Healthy Ad… Ended

2023-506928-83-00 Healthy Volunteers 1 2022-11-12
Bioequivalence clinical trial of two formulations of Pregabalin 300 mg. Ended

2022-501160-18-00 Healthy volunteers 2 2022-09-22
Efficacy of Desmopressin in safaty outcomes post kindey biopsy Ended

2024-516270-30-00 Rare and ultra-rare glomerulonephritis 5 2022-08-25
A multi-center interventional study to assess pharmacokinetics, effectiveness and tolerability of prolonged-release Tacrolimus after Paediat… Ended

2024-516608-40-00 Caucasian paediatric kidney transplant recipients 10 2022-02-23
Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency Ended

2024-516021-32-00 Critically ill patients suffering from CIRCI 5 2022-02-17
Randomised, double-blind, placebo-controlled, active-treatment clinical trial to assess the analgesic efficacy and safety of an oral combina… Ended

2024-517807-35-00 Moderate to severe somatic pain. 5 2022-01-10
Single Dose Pharmacokinetics and Relative Bioavailability of Sayana Press via Upper Arm Injection Relative to Anterior Thigh and Abdomen Ended

2024-513561-39-00 long-term female contraception 3 2021-09-08
Study of Cemiplimab in Patients with type of skin cancer Stage II to IV Cutaneous Squamous Cell Carcinoma Ended

2022-500811-37-00 Stage II to IV cutaneous squamous cell carcinoma 4 2021-01-19
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer Ended

2023-507148-35-00 Chemotherapy-induced Thrombocytopenia in Adult Subjects 5 2019-10-03
Expanded access program for mepolizumab in subjects with hypereosinophilic syndrome. Ended

2024-515247-28-00 Hypereosinophilic Syndrome 5 2019-03-29
Study to evaluate the efficacy and safety of a local anesthetic used in flat foot or inguinal hernia interventions at two different concentr… Ended

2024-518179-76-00 Calcagno stop and inguinal hernia repair 4 2019-03-11
A Study to Evaluate Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination with Atezolizumab in Patients with Locally… Ended

2023-504224-26-00 Advanced tumors 1 2018-07-03
Evaluation of 68GaNOTA-Anti-HER2 VHH1 uptake in brain metastasis of cancer patients Ended

2024-513997-23-00 Cancer patients with brain metastasis 4 2017-10-16
Comparative Bioavailability of Teriflunomide 14 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, … Ended

2024-516401-23-00 No medical condition. 2
Single dose oral bioequivalence study of Cladribine 10 mg Tablets and Mavenclad® 10 mg tablets (Cladribine) in healthy adult human subjects … Ended

2025-522252-74-00 No therapeutic indication in the current trial with hea 2